mk2 Biotech­nolo­gies par­tic­i­pat­ed as emerg­ing start­up at the Bio­Varia 2018 in Munich, Ger­many. The oral and poster pre­sen­ta­tions cat­alyzed fruit­ful dis­cus­sions with tech­nol­o­gy experts from indus­try and finance under­lin­ing the impor­tance of new pep­tide syn­the­sis tech­nolo­gies.